A Concentrated and Stable Aerosol Formulation of Cationic Lipid:DNA Complexes Giving High-Level Gene Expression in Mouse Lung

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Human Gene Therapy

• Publication date

  1997-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/hum.1997.8.6-765PMID 9113516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Basis of Pulmonary Toxicity Associated with Cationic Lipid-Mediated Gene Transfer to the Mammalian Lung

  1997cited by this paper
• Optimization of Formulations and Conditions for the Aerosol Delivery of Functional Cationic Lipid:DNA Complexes

  1997influential reference
• Detailed Analysis of Structures and Formulations of Cationic Lipids for Efficient Gene Transfer to the Lung

  1996influential reference
• Cationic lipids for reporter gene and CFTR transfer to rat pulmonary epithelium.

  1995influential reference
• Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.

  1995cited by this paper
• Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy.

  1995cited by this paper
• Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits.

  1994influential reference
• Cell number and distribution in human and rat airways.

  1994cited by this paper
• Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice

  1993influential reference
• Corrigendum: Non–invasive liposome–mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice

  1993cited by this paper
• Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients.

  1993cited by this paper
• Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer.

  1992cited by this paper
• Aerosol gene delivery in vivo.

  1992cited by this paper
• The Pharmacokinetics of Pulmonary-Delivered Insulin: A Comparison of Intratracheal and Aerosol Administration to the Rabbit

  1992cited by this paper
• Localization and induced expression of fusion genes in the rat lung.

  1991influential reference
• Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

  1987cited by this paper
• Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

  1982cited by this paper

• Lipid-based nucleic acid therapeutics with in vivo efficacy.

  2022cites this paper
• Intranasal gene therapy for the treatment of neurological disorders

  2021cites this paper
• Lipid-Based DNA Therapeutics: Hallmarks of Non-Viral Gene Delivery.

  2019cites this paper
• Recent Developments in mRNA-Based Protein Supplementation Therapy to Target Lung Diseases.

  2019cites this paper
• Current Practices and Potential Nanotechnology Perspectives for Pain Related to Cystic Fibrosis

  2019cites this paper
• Barriers and recent advances in non-viral vectors targeting the lungs for cystic fibrosis gene therapy

  2019cites this paper
• Emerging gene therapies for cystic fibrosis

  2019influential citation
• Emerging Therapies for Cystic Fibrosis

  2019influential citation
• The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins

  2018cites this paper
• Gene Therapy for Cystic Fibrosis: Hurdles to Overcome for Successful Clinical Translation

  2018cites this paper
• Internalization of Vectorized Liposomes Loaded with Plasmid DNA in C6 Glioma Cells

  2017cites this paper
• Gene delivery to the lungs: pulmonary gene therapy for cystic fibrosis

  2017cites this paper
• Lipoplexes in Gene Therapy Under the Considerations of Scaling Up, Stability Issues, and Pharmaceutical Requirements

  2016cites this paper
• A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator ( CFTR) gene therapy in patients with cystic fibrosis

  2016cites this paper
• Barriers to inhaled gene therapy of obstructive lung diseases: A review.

  2016cites this paper
• Targeting the Root Cause of Cystic Fibrosis.

  2015cites this paper
• An investigation into persistent transgene expression from plasmid vectors in the lung

  2015influential citation
• Nonviral Gene Therapy—The Challenge of Mobilizing DNA

  2015cites this paper
• mRNA Modification and delivery strategies towards the establishment of a platform for safe and effective gene therapy

  2015cites this paper
• Aerosol Delivery of DNA/Liposomes to the Lung for Cystic Fibrosis Gene Therapy

  2014influential citation
• Cystic fibrosis gene repair: correction of ΔF508 using ZFN and CRISPR/Cas9 guide RNA gene editing tools

  2013cites this paper
• The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.

  2013cites this paper
• Delivery Systems for Pulmonary Gene Therapy

  2012cites this paper
• Comparison of the gene transfer efficiency of mRNA/GL67 and pDNA/GL67 complexes in respiratory cells.

  2012cites this paper
• Vectors for Inhaled Gene Therapy in Lung Cancer. Application for Nano Oncology and Safety of Bio Nanotechnology

  2012cites this paper
• Sterically polymer-based liposomal complexes with dual-shell structure for enhancing the siRNA delivery.

  2012cites this paper
• Intratracheally instilled mannosylated cationic liposome/NFκB decoy complexes for effective prevention of LPS-induced lung inflammation.

  2011cites this paper
• Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung

  2011cites this paper
• A novel mixing device for the reproducible generation of nonviral gene therapy formulations.

  2010cites this paper
• Gene and Cell Therapy for the Treatment of Cystic Fibrosis

  2009cites this paper
• Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects

  2009cites this paper
• CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression

  2008cites this paper
• Effect of Lyophilization and Freeze-thawing on the Stability of siRNA-liposome Complexes

  2008cites this paper
• Gene delivery to the lung

  2008cites this paper
• Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes.

  2008cites this paper
• Factors Controlling Particle Size during Nebulization of DNA–Polycation Complexes

  2007cites this paper
• Gene Transfer in Differentiated Primary Rat Tracheal Epithelial Cells by Non-Viral Vectors

  2007influential citation
• Identification of transfected cell types following non‐viral gene transfer to the murine lung

  2007cites this paper
• Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung

  2007cites this paper
• Optimizing aerosol gene delivery and expression in the ovine lung.

  2007cites this paper
• Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo

  2006cites this paper
• DNA-Pharmaceuticals: Formulation and Delivery in Gene Therapy, DNA Vaccination and Immunotherapy

  2006cites this paper
• Recent developments in delivery of nucleic acid-based antiviral agents.

  2006cites this paper
• A miniaturized nebulization catheter for improved gene delivery to the mouse lung

  2005cites this paper
• DNA Vaccines for Mucosal Immunity to Infectious Diseases

  2005cites this paper
• Toxicity of Cationic Lipid-DNA Complexes.

  2005cites this paper
• Non-viral gene delivery to the lungs.

  2005cites this paper
• Pre-clinical and clinical endpoint assays for cystic fibrosis gene therapy.

  2005cites this paper
• Toxicity of cationic lipid-DNA complexes.

  2005cites this paper
• Formulation Considerations for DNA-Based Therapeutics

  2004cites this paper
• Biodistribution and pharmacokinetics of aerosol and intravenously administered DNA-polyethyleneimine complexes: optimization of pulmonary delivery and retention.

  2003cites this paper
• A recombinant H1 histone-based system for efficient delivery of nucleic acids.

  2003cites this paper
• RETRACTED: Polyethyleneimine-based gene therapy by inhalation

  2003cites this paper
• Gene Delivery to the Lung

  2003cites this paper
• Aerosol gene therapy

  2003cites this paper
• The re-emergence of aerosol gene delivery: a viable approach to lung cancer therapy.

  2003cites this paper
• Transfection efficiency and toxicity following delivery of naked plasmid DNA and cationic lipid-DNA complexes to ovine lung segments.

  2003cites this paper
• Mechanisms for Cationic Lipids in Gene Transfer

  2003cites this paper
• Topical gene therapy for pulmonary diseases with PEI-DNA aerosol complexes.

  2003cites this paper
• Cationic Lipids for Lung Gene Therapy

  2002cites this paper
• Effects of PEGylation on the preservation of cationic lipid/DNA complexes during freeze-thawing and lyophilization.

  2002cites this paper
• Formulation of synthetic vectors for cystic fibrosis gene therapy.

  2002cites this paper
• Inhibition of nonviral cationic liposome-mediated gene transfer into primary human respiratory cells by interferon-γ

  2002cites this paper
• In Vivo Characteristics of Cationic Liposomes as Delivery Vectors for Gene Therapy

  2002cites this paper
• Proteolipidic vectors for gene transfer to the lung.

  2002cites this paper
• Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus

  2002cites this paper
• Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes.

  2001cites this paper
• Expression of ΔF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR

  2001cites this paper
• Aerosolization of cationic lipid-DNA complexes: lipoplex characterization and optimization of aerosol delivery conditions.

  2001cites this paper
• Use of perfluorocarbon (fluorinert) to enhance reporter gene expression following intratracheal instillation into the lungs of Balb/c mice: implications for nebulized delivery of plasmids.

  2001cites this paper
• A Clinical Inflammatory Syndrome Attributable to Aerosolized Lipid–DNA Administration in Cystic Fibrosis

  2001cites this paper
• Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components

  2001cites this paper
• Physical stabilization of DNA-based therapeutics.

  2001cites this paper
• Gene Therapy for Lung Disease: Hype or Hope?

  2000cites this paper
• Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs

  2000cites this paper
• Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models.

  2000cites this paper
• Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer

  2000cites this paper
• Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization.

  2000cites this paper
• Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA

  2000cites this paper
• Enhanced gene expression in mouse lung after PEI-DNA aerosol delivery.

  2000cites this paper
• Gene transfer by guanidinium‐cholesterol: dioleoylphosphatidyl‐ethanolamine liposome‐DNA complexes in aerosol

  1999cites this paper
• Contribution of Plasmid DNA to Inflammation in the Lung after Administration of Cationic Lipid:pDNA Complexes

  1999cites this paper
• Solvoplex: A New Type of Synthetic Vector for Intrapulmonary Gene Delivery

  1999cites this paper
• Cationic lipid-mediated gene transfer: current concepts.

  1999cites this paper
• Sterically stabilized liposomes in cancer therapy and gene delivery.

  1999cites this paper
• DNA vaccines: technology and application as anti-parasite and anti-microbial agents.

  1999cites this paper
• Cationic Lipid-Mediated Gene Delivery to the Airways

  1999cites this paper
• Cationic lipid:pDNA complexes for the treatment of cystic fibrosis.

  1999cites this paper
• Technology evaluation: cystic fibrosis therapy, Genzyme.

  1999cites this paper
• The Perplexing Delivery Mechanism of Lipoplexes

  1999cites this paper
• CHAPTER 5.3 – Cationic liposome-DNA complexes in gene therapy

  1998cites this paper
• Airway delivery of cationic lipid: DNA complexes for cystic fibrosis.

  1998cites this paper
• Aerosolization of Cationic Lipid:pDNA Complexes—In Vitro Optimization of Nebulizer Parameters for Human Clinical Studies

  1998influential citation
• Direct Gene Transfer to the Respiratory Tract of Mice with Pure Plasmid and Lipid-Formulated DNA

  1998influential citation
• Cationic Phosphonolipids as Nonviral Gene Transfer Agents in the Lungs of Mice

  1998cites this paper
• Target Specific Optimization of Cationic Lipid-Based Systems for Pulmonary Gene Therapy

  1998cites this paper
• Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes.

  1998cites this paper
• Basis of Pulmonary Toxicity Associated with Cationic Lipid-Mediated Gene Transfer to the Mammalian Lung

  1997cites this paper
• Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.

  1997cites this paper
• Safety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to the lungs of normal volunteers

  1997cites this paper